| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0078 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |